Hi Dentie,
I think that the launch into the States was possibly the result of not getting Chinese approval in time and actually turned out to be about a year late.
Cellmid had to do something to move ahead not knowing if and when they would get approval in China.
IMHO the plan of Japan, China, US in that order, if thats correct, got well and truly stymied by no approvals.
Even though they applied well in advance of expiry date for their original licences they were left on the back foot.
Im left wondering how much further ahead we would be if there had been a smooth continuation of licences in China
I really think this is the reason for the current "value challenged " Share Price.
The first two quarters after QVC China gets on board should give us a bit of an indication of how far down the track we should have been a year ago.
Cheers
Pharma
- Forums
- ASX - By Stock
- Ann: CELLMID QUARTERLY OPERATIONAL UPDATE
Hi Dentie, I think that the launch into the States was possibly...
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $350 | 50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 775527 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 5022 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 775527 | 0.006 |
1 | 300000 | 0.005 |
3 | 825000 | 0.004 |
1 | 600000 | 0.003 |
2 | 500000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 5022 | 1 |
0.009 | 280000 | 1 |
0.010 | 157763 | 1 |
0.013 | 750000 | 1 |
0.015 | 340000 | 2 |
Last trade - 11.14am 09/08/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |